Esophagus to Small Intestine

Am J Gastroenterol. 2024;119(10):2002-2009

Strauss Starling A, Ren Y, Li H, Spergel JM, Muir AB, Lynch KL, Liacouras CA, Falk GW

Reducing eosinophil counts in eosinophilic esophagitis in children is associated with reduction in later stricture development


Introduction: There are limited longitudinal data on the impact of chronic therapy on the natural history of eosinophilic esophagitis (EoE), a chronic allergic disease of the esophagus. The purpose of this study was to evaluate if patients with well-controlled EoE were less likely to develop fibrostenotic complications.
Methods: Subjects were identified from a database of pediatric patients with EoE at the Children’s Hospital of Philadelphia started in 2000. Patients were then searched in adult medical records to identify patients who transitioned care. All office visits, emergency department visits, and endoscopic, histologic, and imaging reports were reviewed for the primary outcome of strictures and the secondary outcomes of food impactions and dysphagia. Cox proportional hazard regression was performed for outcomes.
Results: 105 patients were identified with the mean follow-up of 11.4 ± 4.9 years. 52.3% (n = 55) had a period of histologic disease control defined as ≥ 2 consecutive endoscopies with histologic remission. These patients were less likely to develop strictures compared with patients who did not have a period of histologic control (hazard ratio [HR] = 0.232; 95% confidence interval [CI]: 0.084–0.64, p = 0.005). Patients who were diagnosed at younger ages were less likely to develop strictures. Presentation with dysphagia or impaction was associated with higher rate of stricture development.

Discussion: In this cohort study with > 10 years of follow-up, children with eosinophilic esophagitis with a period of histologic disease control and diagnosed at younger ages were less likely to develop esophageal strictures. While this suggests histologic remission is associated with reduction of remodeling complications, additional prospective data with long-term follow-up are needed.

A. Strauss Starling, Division of Gastroenterology & Hepatology, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, E-Mail: alexandra.strauss@pennmedicine.upenn

DOI:  10.14309/ajg.0000000000002830

Back to overview

this could be of interest:

Esophagus to Small Intestine

Preoperative chemoradiotherapy for resectable gastric cancer

N Engl J Med. 2024;391(19):1810-1821

More articles on the topic